Purple Biotech Ltd.
PPBT | NASDAQ
$1.21
+$0.04 (+3.42%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.19 | -10.61 | -8.58 | -11.50 | -38.90 | -15.24 |
PEG Ratio | -0.05 | 0.14 | 0.34 | -0.58 | 0.65 | 1.42 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.25 | 2.34 | 4.99 | 5.31 | 10.92 | 5.40 |
P/FCF Ratio | -5.69 | -5.35 | -8.56 | -14.69 | -46.08 | -34.99 |
P/OCF Ratio | -5.70 | -5.35 | -8.56 | -14.89 | -46.43 | -35.44 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Quick Ratio | 1.27 | 2.23 | 1.63 | 4.71 | 11.41 | 19.14 |
Current Ratio | 1.27 | 2.23 | 1.63 | 4.71 | 11.41 | 19.14 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -704.05 | -268.41 | -397.70 | -337.36 | -227.01 | -236.41 |
Return on Equity | -271.63% | -22.03% | -58.12% | -46.19% | -28.36% | -35.52% |
Return on Assets | -150.16% | -19.55% | -44.87% | -39.67% | -26.19% | -33.64% |
Return on Invested Capital | -272.87% | -33.11% | -64.02% | -47.33% | -27.11% | -16.48% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PPBT